Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer-Reference-Cited by-同舟云学术

Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer

Published:2020-08-11 Issue:6 Volume:27 Page:1147-1157
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Zhong Wenjing,Yang Yaping,Zhang Ailing,Lin Wanyi,Liang Gehao,Ling Yun,Zhong Jiajie,Yong Juanjuan,Liu Zihao,Tian Zhenluan,Lin Qun,Luo Qing,Li Yangyang,Gong Chang^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12282-020-01142-8.pdf

Reference31 articles.

1. Garassino I, Gullo G, Orefice S, Tondulli L, Masci G, Salvini P, et al. Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy. Breast. 2009;18:263–6.

2. Gamucci T, Vaccaro A, Ciancola F, Pizzuti L, Sperduti I, Lea M. Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis. J Cancer Res Clin Oncol. 2013;139:853–60.

3. van Ramshorst MS, van der Heiden-van der Loo M, Dackus GM, Linn SC, Sonke GS. The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer. Breast Cancer Res Treat. 2016;158:361–71.

4. Chia SK, Speers CH, Bryce CJ, Hayes MM, Olivotto IA. Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies. J Clin Oncol. 2004;22:1630–7.

5. Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol. 2009;27:5700–6.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9;International Journal of Oncology;2024-09-02

2. Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments;Nutrition and Cancer;2024-05-09

3. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A;Journal of Experimental & Clinical Cancer Research;2023-11-27

4. Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers;BioMed Research International;2023-11-23

5. Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor;International Journal of Molecular Sciences;2023-09-26